References
- Chang A, Walsh K, Shofer F, et al. Relationship between cocaine use and coronary artery disease in patients with symptoms consistent with an acute coronary syndrome. Acad Emerg Med. 2010;18:1–9.
- Agrawal P, Scarabelli T, Saravolatz L, et al. Current strategies in the evaluation and management of cocaine-induced chest pain. Cardiol Rev. 2015;1:303–311.
- Stankowski R, Kloner R, Rezkalla S. Cardiovascular consequences of cocaine use. Trends Cardiovasc Med. 2015;25:517–526.
- Guirgis F, Gray-Eurom K, Mayfield T, et al. Impact of an abbreviated cardiac enzyme protocol to aid rapid discharge of patients with cocaine-associated chest pain in the clinical decision unit. West J Emerg Med. 2014;15:180–183.
- Hollander J, Henry T. Evaluation and management of the patient who has cocaine-associated chest pain. Cardiol Clin. 2006;24:103–114.
- Korley F, Schulman S, Sokoll L, et al. Troponin elevations only detected with a high-sensitivity assay: clinical correlations and prognostic significance. Acad Emerg Med. 2014;21:727–735.
- Korley F, Jaffe A. High-sensitivity troponin: where are we now and where do we go from here? Biomarkers Med. 2014;8:1021–1032.
- Thygesen K, Mair J, Giannitsis E, et al. How to use high-sensitivity cardiac troponins in acute cardiac care. Eur Heart J. 2012;33:2252–2257.
- Weber J, Chudnofsky C, Boczar M, et al. Cocaine-associated chest pain: how common is myocardial infarction? Acad Emerg Med. 2000;7:873–877.
- Hollander J, Hoffman R, Gennis P, et al. Prospective multicenter evaluation of cocaine-associated chest pain. Acad Emerg Med. 2008;1:330–339.
- Hollander J. Cocaine-associated myocardial infarction. Mortality and complications. Cocaine-Associated Myocardial Infarction Study Group. Arch Intern Med. 1995;155:1081–1086.
- Liaudet L, Calderari B, Pacher P. Pathophysiological mechanisms of catecholamine and cocaine-mediated cardiotoxicity. Heart Fail Rev. 2014;19:815–824.
- Saunders J, Nambi V, de Lemos J, et al. Cardiac troponin T measured by a highly sensitive assay predicts coronary heart disease, heart failure, and mortality in the atherosclerosis risk in communities study. Circulation. 2011;123:1367–1376.
- Latini R, Masson S, Anand I, et al. Prognostic value of very low plasma concentrations of Troponin T in patients with stable chronic heart failure. Circulation. 2007;116:1242–1249.
- Valina C, Amann M, Stratz C, et al. Predictors of high-sensitivity cardiac troponin in stable patients undergoing coronary angiography. EuroIntervention. 2016;12:329–336.
- Goldfrank L, Nelson L. Goldfrank's toxicological emergencies. New York: McGraw-Hill Medical; 2011.